Plasma concentrate and method of processing blood for same
US6214338A · kind A · utility
157Cited by
100References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 25, 2000 |
| Grant date | Apr 10, 2001 |
| Priority date | — |
| Expiry date | Apr 25, 2020 |
Classification
- Technology area (CPC B)Performing Operations; Transporting
- CPC primaryB04B2005/0478
- WIPO fieldChemical engineering
- WIPO sectorChemistry
Abstract
A plasma concentrate comprising one of platelets and platelet releasate and from 5 to 400 mg/ml of fibrinogen. The concentrate further includes a physiologically acceptable carrier comprising water and physiologically acceptable inorganic and organic ions at a physiologically acceptable concentration. The fibrinogen in the concentrate is not significantly denatured. A method for processing blood is further provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.